A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Clinical trial NCT03066804 · COMPLETED
Trial details
- NCT number
- NCT03066804
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-22
- Primary completion
- 2019-10-28
- Enrollment
- 2572
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.